A year ago today we launched the world’s biggest real-world study into COVID-19 antibodies. As infections soared around the world, we set up the SIREN study to start looking for answers to some of the most important questions about reinfection and the impact of antibodies.
In the past year SIREN has carried out 519,465 PCR tests, 249,402 blood tests, with 44,549 participants across 135 sites. Participants are tested every 2-4 weeks using both PCR and antibody tests. All in the interest of answering the questions that we and the public need to know.
Here are five things that we have learnt from the study so far:
1 - Can reinfection occur from COVID-19?
This was one of the biggest questions we needed to answer as it would have a huge impact on how the pandemic might progress and how we would manage it. From the study we learnt last year that reinfection was possible and could occur, although it was reasonably rare.
Once we had the answer to this it led to the next obvious question
2 - Do antibodies offer you protection?
We wanted to understand what, if any, protection people who have antibodies might have from the virus. How long would they last, was it possible to recover from COVID-19 but then get it straight away?
The evidence from SIREN suggested that antibodies would offer some degree of protection for several months after infection. When SIREN reported its first analysis, the study showed that 83% of people infected with COVID-19 had protection against reinfection for at least 9 months.
3 - How effective are the vaccines?
To answer some of the vaccine questions we expanded the number of participants in the study to collect additional vaccination data and increased recruitment around the time that vaccination of healthcare workers started. This helped us to assess the effectiveness of vaccines.
SIREN analysis from February showed that healthcare workers were 72% less likely to develop infection, both symptomatic and asymptomatic, after one dose of the vaccine, rising to 86% after the second dose. Incredible numbers showing us that the way out of the pandemic was to vaccinate. It also showed us that individuals who were vaccinated had a milder illness and were more likely to have infections without symptoms.
4 - How long does it take for the vaccines to work?
At the same time, SIREN found that protection from the vaccine begins two weeks after the first dose but is optimal from 2 weeks after the second dose. This was key information to help us understand how we could move forward as we started to vaccinate the country.
Analysis also showed that this protection helps to reduce the spread of infection. If an individual is not infected, they cannot spread the virus; the more individuals who cannot spread the virus, the greater protection for the whole population.
5 - What more can we find out?
It has been a difficult 15 months for us all but scientific studies have helped us to understand what we are dealing with, how to manage the pandemic, and will continue to help us as we move forward.
Since its creation, the SIREN study has answered some of the most important questions about COVID-19 infection, reinfection and antibodies. But our work is not over and there is much more to do.
We are assessing what level of antibodies those who had a reinfection have versus those that did not.
We will continue to monitor participants closely to see the impact of antibodies and vaccines on COVID-19 over the next 12 months, understanding the durability of the vaccine response and measuring the impact of any future COVID vaccines on the immune response and protection against infection.
These discoveries would not be possible without the work and effort by so many people. Especially the NHS researchers and volunteer participants who give up their time in the interest of science.
Which is why I am delighted the study will continue this vital work over the coming year to help answer the mysteries of a virus that, just 18 months ago, had not yet been identified. These discoveries would not be possible without the efforts of so many people, especially the participants who give up their time in this vital act of public service.
8 comments
Comment by Mariella Sardi posted on
Very interesting Research; I have a question regarding immunity effect of Vaccine in Auto Inmune Patients, like with Lupus, Rheumatoid Arthritis etc.
I am a 73 years old female with both pathologies.
Congratulations and our Gratitude for your Humanitarian work!!!
Comment by Geoff Went posted on
Thanks for the brilliant work in exceptional circumstances. Long may it continue until the virus is totally understood in all its characteristics
Comment by Keith Hermon posted on
Well done to you all
Comment by Pauline Bright posted on
I’ve been on the Siren study for a year next week as an NHS worker I am glad to contribute to this study and hopefully I will be doing it for another year. Thanks to all the Siren team at Broomfield Hospital Chelmsford
Comment by Ciaran posted on
We need to know how long the vaccine provides protection and when do we need a booster. Also what vaccines are being developed against new variants
Comment by Cees Bakker. Netherlands posted on
I read this study with great interest and I am proud of my daughter-in-law that she is involved in this research.
Comment by Mrs Lisa B Overton posted on
Thank you
Comment by Robert Mackenzie posted on
Great study. Thanks all. One thing I don't understand - if infection offers similar protection to vaccination, why are we pushing vaccination for all and not using the vaccines where they are needed more? With 4.6million officially infected, we could have helped vaccinate a few small countries. Surely, the solution needs to be global.